Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis
about
Improving the clinical impact of biomaterials in cancer immunotherapy.Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016.Effect of Chitosan Properties on Immunoreactivity.Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer.Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis.Delivering safer immunotherapies for cancer.
P2860
Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Neoadjuvant immunotherapy with ...... ntrol breast cancer metastasis
@ast
Neoadjuvant immunotherapy with ...... ntrol breast cancer metastasis
@en
type
label
Neoadjuvant immunotherapy with ...... ntrol breast cancer metastasis
@ast
Neoadjuvant immunotherapy with ...... ntrol breast cancer metastasis
@en
prefLabel
Neoadjuvant immunotherapy with ...... ntrol breast cancer metastasis
@ast
Neoadjuvant immunotherapy with ...... ntrol breast cancer metastasis
@en
P2093
P2860
P1433
P1476
Neoadjuvant immunotherapy with ...... ntrol breast cancer metastasis
@en
P2093
Bhanu Prasanth Koppolu
Jimmy Ln Vo
Lirong Yang
Samantha L Kurtz
Sean G Smith
P2860
P304
P356
10.4161/21624011.2014.968001
P577
2014-12-01T00:00:00Z